At long last, cancer survival statistics are beginning to reveal real progress. From 1991 to 2015, the cancer death rate in the U.S. dropped by 26 percent, resulting in an estimated 2.4 million fewer cancer deaths. In 2016, more than 15.5 million Americans with a history of cancer were alive; that number is projected to exceed 20 million by 2026. The U.S. health care system faces a looming challenge: how to deal with the wide array of health and wellness aftereffects faced by children and adults who were once cancer patients.Read More
Thanks to decades of cancer research that have brought us groundbreaking discoveries and treatments, 15.5 million U.S. cancer survivors have more time to spend with their loved ones. That number is only going up, to an estimated 26.1 million by 2040.
For most of these survivors, their journey comes with complications and lasting side effects. Many continue to deal with the physical, mental, and emotional impact of their cancer diagnosis long after their final treatment. Thousands of survivors face financial challenges resulting from or made worse by their cancer diagnosis and treatment.Read More
Anthracyclines, a widely used class of chemotherapeutics, work in several ways to kill rapidly dividing cells, including those found in a tumor. While these drugs are commonly used to treat many types of adult and childhood cancer, they have a detrimental side effect – cardiotoxicity.
The cardiotoxicity of anthracyclines is dose-dependent; the more exposure patients have to the drug, the more serious risk they carry for heart-related problems. This can represent a unique challenge in children treated with anthracyclines, whose hearts are still developing.Read More
A young adult shares his story of leaving college and learning to rely on his mother as he battled leukemia.Read More
Cancer Today Senior Editor Marci A. Landsmann shares her experience reporting on a young lung cancer survivor, Emily Bennett Taylor, who dreamed of starting a family.Read More
Researchers have well established that smoking leads to adverse outcomes in cancer patients; however, the specific effects caused by smoking and the use of other tobacco products remain poorly understood …Read More
As more people are surviving cancer, there’s growing concern about how to care for their needs and improve long-term quality of life for patients and their families. That’s the essence of palliative care.Read More
Aime Franco, PhD, quietly battled cancer throughout her undergraduate years at the University of Connecticut. But even as she tried to conceal her illness, a seed planted that would set her on a quest to understand more about cancer.Read More
“Easing the Pain” tells the story of cancer patients’ experiences dealing with pain and best practices for pain management. The article is featured in the Spring 2016 issue of Cancer Today, a magazine for cancer patients, survivors, and caregivers that is published by the American Association for Cancer Research.Read More
Late last week, the U.S. Food and Drug Administration (FDA) approved a new treatment for one of the most common types of soft tissue sarcoma, liposarcoma. The therapeutic, eribulin mesylate …Read More